Does RUXOLITINIB Cause Flatulence? 463 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 463 reports of Flatulence have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.7% of all adverse event reports for RUXOLITINIB.
463
Reports of Flatulence with RUXOLITINIB
0.7%
of all RUXOLITINIB reports
28
Deaths
91
Hospitalizations
How Dangerous Is Flatulence From RUXOLITINIB?
Of the 463 reports, 28 (6.0%) resulted in death, 91 (19.7%) required hospitalization, and 5 (1.1%) were considered life-threatening.
Is Flatulence Listed in the Official Label?
Yes, Flatulence is listed as a known adverse reaction in the official FDA drug label for RUXOLITINIB.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Flatulence?
ADALIMUMAB (1,651)
POLYETHYLENE GLYCOL 3350 (1,207)
VEDOLIZUMAB (949)
SEMAGLUTIDE (925)
TIRZEPATIDE (918)
LENALIDOMIDE (865)
NINTEDANIB (832)
DULAGLUTIDE (754)
OCTREOTIDE (699)
APREMILAST (617)
Which RUXOLITINIB Alternatives Have Lower Flatulence Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE